Previous Close | 0.2950 |
Open | 0.2900 |
Bid | 0.2950 x N/A |
Ask | 0.2950 x N/A |
Day's Range | 0.2900 - 0.2950 |
52 Week Range | 0.1950 - 2.0900 |
Volume | |
Avg. Volume | 14,196 |
Market Cap | 38.542M |
Beta (5Y Monthly) | 2.37 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.9800 |
Earnings Date | Aug 05, 2024 - Aug 10, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.60 |
BURLINGTON, Ontario, May 20, 2024--Anaergia Inc. ("Anaergia" or the "Company") (TSX: ANRG) announced today that there will be a longer than previously anticipated delay in the filing of its annual information form for the year ended December 31, 2023, audited annual consolidated financial statements for the year ended December 31, 2023, the related management’s discussion and analysis of financial condition and results of operations and CEO and CFO certificates relating to the audited annual fin
BURLINGTON, Ontario, May 07, 2024--Anaergia Inc. ("Anaergia" or the "Company") (TSX: ANRG) announced today the acceptance of Mr. Frank McKenna’s resignation from the Company’s board of directors effective as of May 5, 2024. Previously, Mr. McKenna had agreed to resign concurrently with the closing of the final tranche of the announced equity investment of C$40.8 million ("Strategic Investment") from Marny Investissement SA ("Marny") (which remains outstanding) in order to create a vacancy for th
BURLINGTON, Ontario, May 04, 2024--Anaergia Inc. ("Anaergia" or the "Company") (TSX: ANRG) announced today that there will be an additional delay in the filing of its annual information form for the year ended December 31, 2023, audited annual consolidated financial statements for the year ended December 31, 2023, the related management’s discussion and analysis of financial condition and results of operations and CEO and CFO certificates relating to the audited annual financial statements as re